Kalvista Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Kalvista Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kalvista Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kalvista Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $448k | 28k | 16.15 |
| 2025-09-30 | $166k | 14k | 12.18 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas